Axon tracker
Axon’s sales from software and devices, quarter by quarter, its new AI and drone products, plus results, directors’ share deals and the latest news.
Sales by business
Axon sells devices like TASERs and body cameras, and the software and cloud services that go with them.
Apr–Jun 2026
- Software and services+36% on a year ago$398m44%
- Connected devices+35% on a year ago$507m56%
The last five quarters
| Q2 2025Apr–Jun 2025 | Q3 2025Jul–Sep 2025 | Q4 2025Oct–Dec 2025 | Q1 2026Jan–Mar 2026 | Q2 2026Apr–Jun 2026 | |
|---|---|---|---|---|---|
| Software and services | $292m | $305m | $343m | $355m | $398m |
| Connected devices | $376m | $405m | $454m | $453m | $507m |
Products and progress
Where each Axon product has got to, from first announcement to widely available. Checked against Axon’s Q2 2026 report (5 Aug 2026).
Devices
-
TASER 10 Widely available
Record TASER order from a major US city in Apr–Jun 2026
Axon’s newest TASER energy weapon. Axon Q2 2026 results
-
Axon Body 4 Widely available
Helped device sales grow 35% in Apr–Jun 2026
Body-worn camera for police officers. Axon Q2 2026 results
-
Dedrone counter-drone Widely available
Revenue now over $100m a year; protected all 11 US World Cup stadiums
Systems that detect and stop unwanted drones. Axon Q2 2026 results
Software
-
AI Era Plan Early rollout
AI revenue up nearly 700% on a year earlier
AI tools that help officers write reports and search evidence. Axon Q2 2026 results
-
Axon 911 Early rollout
First full customer signed in Apr–Jun 2026
Software for emergency call centres. Axon Q2 2026 results
What’s new
The last 30 days. Headlines link to the full stories on the publishers’ own sites.
Numbers
Sales each quarter
Net profit each quarter
| Quarter | Months | Sales | Net profit |
|---|---|---|---|
| Q2 2026 | Apr–Jun 2026 | $904m | $29.4m |
| Q1 2026 | Jan–Mar 2026 | $807m | $169m |
| Q4 2025 | Oct–Dec 2025 | $797m | $2.7m |
| Q3 2025 | Jul–Sep 2025 | $711m | −$2.2m |
| Q2 2025 | Apr–Jun 2025 | $669m | $36.1m |
From Axon’s results filed with the SEC; newer quarters appear automatically, with the business split added after each report is checked.
Directors’ share deals
Directors and senior staff must tell the SEC within two business days when they buy, sell or are given shares.
| Reported | Who | What happened |
|---|---|---|
| 2 Oct 2026 | Cameron BrooksCHIEF REVENUE OFFICER | Shares kept back for tax 5,850 shares |
| 14 Sep 2026 | Isaiah FieldsChief Legal Officer | Sold 1,017 shares at $480.45 ($488,618) |
| 10 Sep 2026 | Patrick W SmithCHIEF EXECUTIVE OFFICER, Director | Sold 10,000 shares at $508.99 ($5.1m) |
| 2 Sep 2026 | Jennifer H MakChief Accounting Officer | Shares kept back for tax 156 shares |
| 2 Sep 2026 | Cameron BrooksCHIEF REVENUE OFFICER | Shares kept back for tax 735 shares |
| 2 Sep 2026 | Elizabeth Reid CoughlinChief Human Officer | Shares kept back for tax 479 shares |
| 2 Sep 2026 | Isaiah FieldsChief Legal Officer | Shares kept back for tax 763 shares |
| 2 Sep 2026 | Joshua IsnerPRESIDENT | Sold 16,775 shares at $574.43 ($9.6m) |
From Form 4 filings on SEC EDGAR. ‘Used options’ means turning share options into shares; it is not a purchase on the market.
Share price
Open the full chartChart by TradingView. Prices may be delayed. This page is not investment advice.
Timeline
- Aug 202610th quarter in a row of sales growth above 30%.
- Feb 2026Sets a target of $6bn of yearly sales by 2028.
- Apr 2017Renamed Axon, as body cameras and software grow.
- May 2001Shares listed on Nasdaq.
- 1993Rick and Tom Smith found the company that becomes TASER International.
On X
Posts worth seeing will be added here. Meanwhile, these are the accounts to follow:
- @axon_us Axon’s main account
What do you think?
Share your view on Axon with other ChartsView members.
Start an Axon thread on the forumWhere this comes from
- US filings, results, buybacks and insider deals: SEC EDGAR
- Sales by business: Axon’s quarterly results
- Headlines: TechCrunch
- Products, cities and timeline: checked by ChartsView against the company’s own reports, last on 28 Oct 2026.
All sources are free and public. Data is collected each morning and refreshed through the day. This page is for information only and is not investment advice.
ChartsView is independent and is not connected with, or endorsed by, Axon Enterprise, Inc. The company’s name is used only to say who this page is about.